Cambridge Investment Research Advisors, Inc. Eli Lilly & CO Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 164,834 shares of LLY stock, worth $123 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

164,834

Previous 167,879 1.81%

Holding current value

$123 Million

Previous $152 Million 3.92%

% of portfolio

0.5%

Previous 0.56%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$772.14 - $960.02 $2.35 Million - $2.92 Million	-3,045 Reduced 1.81%	164,834 $146 Million
Q2 2024 Jul 26, 2024	BUY	$724.87 - $909.04 $1.77 Million - $2.22 Million	2,446 Added 1.48%	167,879 $152 Million
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $2.11 Million - $2.82 Million	3,559 Added 2.2%	165,433 $129 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $1.99 Million - $2.34 Million	-3,784 Reduced 2.28%	161,874 $94.4 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $3.35 Million - $4.62 Million	-7,717 Reduced 4.45%	165,658 $89 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $7.21 Million - $9.64 Million	20,551 Added 13.45%	173,375 $81.3 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $2.53 Million - $2.97 Million	8,149 Added 5.63%	152,824 $52.5 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $2.24 Million - $2.61 Million	6,975 Added 5.07%	144,675 $52.9 Million
Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $3.51 Million - $4 Million	11,846 Added 9.41%	137,700 $44.5 Million
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $324,720 - $381,269	-1,165 Reduced 0.92%	125,854 $40.8 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $4.71 Million - $5.86 Million	20,089 Added 18.79%	127,019 $36.4 Million
Q4 2021 Feb 03, 2022	BUY	$224.85 - $279.04 $1.16 Million - $1.44 Million	5,164 Added 5.07%	106,930 $29.5 Million
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $394,891 - $485,969	-1,782 Reduced 1.72%	101,766 $23.5 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $685,728 - $886,984	-3,798 Reduced 3.54%	103,548 $23.8 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $664,838 - $860,665	4,046 Added 3.92%	107,346 $20.1 Million
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $320,409 - $423,979	-2,456 Reduced 2.32%	103,300 $17.4 Million
Q3 2020 Oct 29, 2020	BUY	$146.22 - $169.13 $777,013 - $898,756	5,314 Added 5.29%	105,756 $15.7 Million
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $430,132 - $517,659	3,153 Added 3.24%	100,442 $16.5 Million
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $672,394 - $832,232	-5,648 Reduced 5.49%	97,289 $13.5 Million
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $292,640 - $362,460	2,737 Added 2.73%	102,937 $13.5 Million
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $141,176 - $153,563	-1,322 Reduced 1.3%	100,200 $11.2 Million
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $81,160 - $88,281	-760 Reduced 0.74%	101,522 $11.4 Million
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $100,929 - $117,810	-911 Reduced 0.88%	102,282 $0
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $5.5 Million - $6.48 Million	-49,451 Reduced 32.4%	103,193 $0
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $269,939 - $302,413	-2,549 Reduced 1.64%	152,644 $17.7 Million
Q3 2018 Nov 02, 2018	BUY	$85.86 - $107.31 $505,629 - $631,948	5,889 Added 3.94%	155,193 $0
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $351,853 - $403,818	-4,648 Reduced 3.02%	149,304 $0
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $3.56 Million - $4.2 Million	47,938 Added 45.22%	153,952 $0
Q4 2017 Feb 22, 2018	BUY	$81.94 - $87.89 $559,650 - $600,288	6,830 Added 6.89%	106,014 $0
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $1.04 Million - $1.16 Million	13,542 Added 15.81%	99,184 $8.48 Million
Q2 2017 Aug 08, 2017	BUY	N/A	85,642	85,642 $7.05 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Eli Lilly & CO Transaction History